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ABSTRACT OF THESIS

SYNTHESIS AND CHARACTERIZATION
OF BLUE LIGHT POLY(β-AMINO ESTER)S

Volumetric muscle loss (VML) is a debilitating injury which results in full or
partial loss of function. Current clinical options utilize tissue grafts and bracing to restore
function. Tissue graft implantation oftentimes leads to serious complications, some of
which end in graft rejection and thereby necessitate further surgeries and procedures.
Polymeric scaffolds show promise as scaffolding systems due to their mechanical
properties and overall degradation profiles. Scaffolds need appropriate mechanical
properties, 10-60 kPa modulus, and overall degradation times, five days to two weeks, to
initiate tissue regeneration. Poly(β-amino ester)s (PBAE), a class of synthetic polymers,
act as a safe biocompatible material with overall degradation times that are suitable for
healing; however, due to harmful ultraviolet light (UV) irradiation from common
crosslinking methods, these scaffold systems cannot be synthesized in vivo. This research
presents the development and characterization of blue light (BL) crosslinked PBAEs. BL
PBAEs showed vastly higher swelling ratios, 300-400% increase; decreased mechanical
strength, an average decrease of 877 kPa in compressive modulus and 431 kPa in tensile
modulus; and prolonged degradation patterns, 22% average mass retention. BL PBAEs
show mechanical properties and degradation profiles that could be used as a skeletal
muscle scaffolds.

Keywords: PBAE, volumetric muscle loss, scaffold, hydrogel, blue light

Nicholas John Kohrs
September 13, 2018

SYNTHESIS AND CHARACTERIZATION
OF BLUE LIGHT POLY(β-AMINO ESTER)S

By
Nicholas John Kohrs

David A. Puleo
Director of Thesis
Abhijit R. Patwardhan
Director of Graduate Studies

Date 10/25/18

ACKNOWLEDGEMENTS
I would like to thank Dr. Puleo for giving me the opportunity to work in his lab. Dr.
Puleo’s knowledge and guidance was invaluable to this research. The wisdom and
knowledge imparted to me will be invaluable for years to come. I would also like to thank
Dr. Pham and Dr. Zhang for their help and expertise in this research.
I would also like to thank my family, especially my fiancée. Their support and
encouragement during these last couple years has pushed me during this great endeavor. I
would finally like to thank my labmates for their time and knowledge which helped advance
my research.

iii

TABLE OF CONTENTS
ACKNOWLEDGEMENTS ................................................................................................. iii
LIST OF TABLES ............................................................................................................... vi
LIST OF FIGURES .............................................................................................................vii
INTRODUCTION................................................................................................................. 1
BACKGROUND AND SIGNIFICANCE .............................................................................. 2
Wound healing response ............................................................................................ 2
Chronic wounds ......................................................................................................... 5
Volumetric muscle loss .............................................................................................. 6
Clinical need .............................................................................................................. 7
Regenerative approaches ............................................................................................ 7
Decellularized tissue scaffolds ........................................................................ 8
Polymeric scaffolds ........................................................................................ 9
Poly(β-amino ester) ..................................................................................... 10
Polymer crosslinking ............................................................................................... 10
Significance ............................................................................................................. 11
MATERIALS AND METHODS ......................................................................................... 12
Materials .................................................................................................................. 12
Macromer synthesis ................................................................................................. 12
Hydrogel fabrication ................................................................................................ 13
PBAE characterization ............................................................................................. 14
In Vitro degradation ..................................................................................... 14
Porosity ........................................................................................................ 14
Mechanical testing ....................................................................................... 15

iv

Drug release pilot study ........................................................................................... 15
Statistical analysis ................................................................................................... 16
RESULTS

..................................................................................................................... 17

Degradation study .................................................................................................... 17
PBAE degradation and swelling profiles ...................................................... 17
BL and UV degradation profiles ................................................................... 19
BL and UV swelling profiles ........................................................................ 21
X-ray microtomography ............................................................................... 23
pH profiles ................................................................................................... 26
Mechanical study ..................................................................................................... 28
Compressive and tensile Modulus ................................................................ 28
Drug Release Pilot ................................................................................................... 32
DISCUSSION ..................................................................................................................... 33
CONCLUSION ................................................................................................................... 39
APPENDIX

..................................................................................................................... 40

REFERENCES.................................................................................................................... 44
VITA

..................................................................................................................... 49

v

LIST OF TABLES

Table 1: FDA approved decellularized scaffolds .................................................................... 8
Table 2: Polymers for scaffold fabrication ............................................................................. 9
Table 3: * BL and UV crosslinked hydrogel means which are statistically different are
marked with asterisks (*) (p < 0.05) ................................................................................... 31

vi

LIST OF FIGURES

Figure 1: Summary of wound healing process ....................................................................... 2
Figure 2: Normal wound healing process ............................................................................... 4
Figure 3: Development of a chronic wound ........................................................................... 6
Figure 4: (A) Chemical structures of diacrylates and amine used to form macromers. (B)
Macromer synthesis reaction ............................................................................................... 12
Figure 5: Polymer degradation (a) and swelling (b) profiles for all UV hydrogels. Data are
mean ± standard deviation (n = 9)........................................................................................ 18
Figure 6: BL and UV degradation profiles for hydrogels (a) AH6 3:1, (b) DH6 3:1, and (c)
H6. Data are mean ± standard deviation (n = 9). Data sets AH6 3:1 and H6 exhibit UV and
BL degradation curves which are statistically different (p< 0.05) after time point day 4 and
hour 1.25, respectively ........................................................................................................ 20
Figure 7: BL and UV swelling profiles for (a) AH6 3:1, (b) DH6 3:1, and (c) H6. Data are
mean ± standard deviation (n = 9). All data sets are significantly different (p < 0.001) after
time point day 1.26 (AH6 3:1), day 1.5 (DH6 3:1), and hour 0.66 (H6) ............................... 22
Figure 8: Porosity, pore size, and wall thickness between pores shown. Data are mean ±
standard deviation (n = 3) .................................................................................................... 24
Figure 9: Evaluating hydrogel microarchitecture of BL and UV crosslinking methods. Data
points which are significantly different are marked with a bar and asterisks (*) (p < 0.05). 25
Figure 10: pH of the hydrogel supernatant for A6 and D6. Data are mean ± standard
deviation (n = 3) .................................................................................................................. 26
Figure 11: pH measurements for (a) AH6 3:1, (b) DH6 3:1, and (c) H6. Data are mean ±
standard deviation (n = 3). Data points which are significantly different (p < 0.05) are marked
with asterisks (*) ................................................................................................................. 27
Figure 12: Representative load-deformation curves for (a) compression and (b) tensile testing
of sample AH6 3:1 .............................................................................................................. 28
Figure 13: Representative stress-strain curves for (a) compression and (b) tension. Red line
indicates the slope of the given data used for calculating the modulus ................................. 29

vii

Figure 14: Modulus for (a) compression and (b) tension. Data are mean ± standard deviation
(n = 4). Outliers are denoted by red plus signs ..................................................................... 30
Figure 15: Release of vancomycin and ketoprofen from DH6 3:1 BL and UV hydrogels,
respectively (n = 1) .............................................................................................................. 32

viii

INTRODUCTION
Volumetric muscle loss is a debilitating injury where the body is unable to heal,
resulting in full or partial loss of function. The primary cause of volumetric muscle loss
involves instances of high tissue loss such as traumatic injuries and surgical procedures.
Commonly this injury results in the development of necrotic tissues, decreased strength and
reduced range of motion. Depending upon the severity of the injury, treatment can vary from
simple bracing techniques to complex surgical procedures; all with the ultimate aim of
restoring function to the damaged tissues. The standard of care for this injury is the
implantation of tissue grafts into the wound area.
Tissue implantation, autologous or allogenic, have several complications that affect
the success of the implant. Immune response, disease transmission, donor site morbidity, and
decreased range of motion and strength are all possible complications that could arise from
treatment. All of these complications pose the risk of graft failure, resulting in another
surgery to further remove necrotic tissue costing more time and money. Logistically, the lack
of available tissue grafts further diminishes the viability of this treatment strategy.
This research focused on the development and characterization of a blue light (BL)
poly (β-amino ester) (PBAE) system with the long term aim of in vivo polymerization. This
system utilized a BL irradiation source with its water-soluble photoinitiator to allow PBAE
crosslinking. Against the common UV crosslinking method, PBAEs were characterized by
examining their physical and mechanical properties, more specifically: degradation and
swelling profiles, changes in supernatant pH, modulus under tension and compression, and
hydrogel microarchitecture. Characterizing the physical and mechanical properties of the BL
PBAE scaffolding system allows for better insights to its possible applications.
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BACKGROUND AND SIGNIFICANCE
Wound Healing Response
The wound healing response is a complex process involving many spatiotemporal
overlapping processes including inflammation, tissue formation, and tissue remodeling [1-3].
Without any of these processes, healing cannot proceed and can lead to the development of
chronic wounds. The wound healing process is shown in Figure 1. In normal wound healing
immediately after occurrence of injury; vasoconstriction, of nearby vasculature, occurs as
immune cells and platelets begin to flood to the wound area starting the clotting cascade.

Figure 1: Summary of wound healing process. Adapted from Seifert, A.W., et al., Skin
Regeneration in Adult Axolotls: A Blueprint for Scar-Free Healing in Vertebrates. PLoS
ONE, 2012. 7(4): p. e32875.
As platelets invade the wound area they begin to come into contact with components
of the extracellular matrix (ECM) causing release of numerous cytokines, chemokines, and
growth factors; such as epidermal growth factor, transforming growth factor-β (TGF-β),
vascular endothelial cell growth factor (VEGF), and platelet-derived growth factor (PDGF)
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[1, 4, 5]. This release causes further platelet aggregation and recruitment of fibrinogen to the
wound area for the formation of a platelet plug; while simultaneously, the fibrinogen is
converted into fibrin by thrombin. Fibrin is crosslinked and further stabilized by factor XIII
to form a fibrin clot; which serves for local cell adhesion, modulates cell responses, and acts
as a reservoir for growth factors, proteases, and protease inhibitors [6].
Near the end of the clotting cascade, the inflammation phase begins calling in
multiple types of immune cells i.e. neutrophils, monocytes, and lymphocytes to the wound
area, as seen in Figure 2 [4, 6]. Neutrophils are among the first immune cell to enter the
wound area. Upon entering the wound area neutrophils begin to phagocytize any remnant
tissue debris from the injury and form neutrophil extracellular traps to capture invading
pathogens. These cells also have over 700 proteins stored inside including growth factors and
pro-angiogenic factors, and upon activation can release these factors to aid in wound healing
[7]. Apoptotic neutrophils aid in wound healing by releasing tissue repairing cytokines i.e.
TGB-β and Interlukin-10, further accelerating tissue repair [7]. Monocytes enter into the
wound area and upon seeing the ECM become macrophages. These immune cells serve to
remove spent neutrophils, apoptotic cells, and other debris; fight infection; promote and
conclude inflammation; and secrete growth factors and cytokines e.g. TGF-β, transforming
growth factor α (TGF-α), heparin binding epidermal growth factor, fibroblast growth factor
(FGF), and collagenase that activate and recruit endothelial cells, fibroblasts, and
keratinocytes to the wound site [2, 4-6]. Little is known about the last immune cell to enter
the wound area, lymphocytes; but there is evidence to suggest they play a role in the
reorganization of keratinocytes and fibroblasts [4, 8]. The proliferative phase, in parallel with
the inflammatory phase, is identified by angiogenesis and the formation of granulation
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tissues [1, 4, 6]. The cytokines and growth factors, produced by the clotting cascade, begin to
recruit fibroblasts, keratinocytes, and endothelial cells to the wound.

Figure 2: Normal wound healing process. From Eming, S.A., P. Martin, and M. TomicCanic, Wound repair and regeneration: Mechanisms, signaling, and translation. Science
Translational Medicine, 2014. 6(265): p. 265sr6-265sr6. Reprinted with permission from
AAAS.
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In response to growth factors such as PDGF, TGF-β, and FGF; fibroblasts proliferate
and produce new ECM materials e.g. collagen I

& III, proteoglycans, and

glycosaminoglycans [4]. Concurrently, capillary sprouts develop and begin to migrate into
the wound, allowing for the transport of nutrients and oxygen to the surrounding tissues.
Later in the proliferative stage, fibroblasts near the edge of the wound, differentiate into
myofibroblasts, and overtime, close the wound. Remodeling of the microenvironment occurs
over the next year as functionality is eventually restored to the damaged tissues. This is
completed by altering ECM proteins from being mostly comprised of collagen III to collagen
I via matrix metalloproteinases and the formation of collagen fiber bundles [9, 10].
Chronic Wounds
Wound healing is a vastly complex process where the disturbance of any cellular or
biochemical process could delay or prevent healing; bringing about chronic, non-healing
wounds [5]. Non-healing wounds can develop at any time in the wound healing process i.e.
inflammation, proliferation, and tissue remodeling. Healing oftentimes stalls during the
inflammatory phase (Figure 3); as persistent inflammation causes an upregulation of proinflammatory cytokines, creating an excessive number of proteases leading to ECM
degradation [11]. During proliferation, inappropriate levels of macrophages, fibroblasts, and
keratinocytes can stall the wound healing process [4, 6, 8]. Tissue hypoxia, infection, disease,
and age are other factors that inhibit wound healing. As stated, wound healing is a complex
process involving many different signals, cells, and tissues in which the slightest miscue can
cause the development of a chronic wound.

5

Figure 3. Development of a chronic wound. From Eming, S.A., P. Martin, and M. TomicCanic, Wound repair and regeneration: Mechanisms, signaling, and translation. Science
Translational Medicine, 2014. 6(265): p. 265sr6-265sr6. Reprinted with permission from
AAAS.
Volumetric Muscle Loss
For an average individual, skeletal muscle accounts for more than 40% of the total
body mass [12]. Traumatic injuries, surgical procedures, and other incidences of high tissue
loss are a few instances where the body is not able to heal and results in partial or total loss of
function. These types of wounds are classified as volumetric muscle loss (VML). VML has
been highly problematic for the military and its effects are seen in recent military conflicts
i.e. Operation Enduring Freedom and Operation Iraqi Freedom; where the majority of
injuries sustained involve severe musculoskeletal injury [13]. Of all battlefield injuries, 54%
of cases present extremity injuries, with soft tissue injures making up 53% of these cases.
Due to these injuries countless military personnel have suffered partial or complete loss of
function. VML cost the United States over 4 billion dollars in hospital expenses and loss of
production (2010 data) [13]. VML not only affects military personnel but also civilians as an
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estimated 4.5 million reconstructive surgeries involving tumor removals were completed in
2017 [14]. These procedures remove massive sections of tissue; oftentimes, leading to tissue
deformation and loss of function. Not only does VML have an enormous economic cost but it
also bears a huge psychological burden on the patient and the patient’s family. The need for a
viable treatment to VML has never been more pressing.
Clinical Need
The standard of care is dependent upon the severity of the injury sustained, as
bracing, tissue implantation, and regenerative strategies have been used to treat VML [3, 12,
13, 15-17]. Tissue implantation i.e. autologous implantation is the preferred method for
dealing with severe cases of VML. In autologous implantation a tissue graft is taken from the
patient and is used to replace damaged tissues, while minimizing the immune response from
the body. One disadvantage of this system is the lack of available autologous grafts. Research
is being conducted on allogenic muscle grafts as a possible option; however, the possibility
of disease transmission and graft rejection are inherent disadvantages to using an allogenic
transplant [18]. Even with the possibility of negating an immune response; donor site
morbidity, loss of strength, and decreased function are common issues that diminish the
viability of tissue implantation. Complications such as infection and tissue necrosis, cause
10% of these surgeries to fail [15]. While tissue implantation minimizes the immune
response, better alternatives are needed to mitigate negative side effects and low implant
availability.
Regenerative Approaches
Regenerative medicine has been primarily focused on the development of scaffolding
systems that mimic the ECM. These systems are designed to promote cell-biomaterial
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interaction, control scaffold degradation and the exchange of important nutrients and growth
factors,

maintain

mechanical

stability

with

appropriately

designed

shape

and

microarchitecture, and elicit minimal response from the immune system [15, 19-22]. Current
research focuses on the development of decellularized tissue scaffolds and the fabrication of
polymeric scaffolds.
Decellularized Tissue Scaffolds
Currently several decellularized tissue scaffolds (Table 1) have been approved by the
FDA. These scaffolds, mostly derived from bovine or porcine animals, are rich in latent
growth factors such as basic fibroblast growth factor (bFGF) and vascular endothelial growth
factor (VEGF), and have been shown to alter the wound microenvironment from one that
induces fibrosis to one that promotes remodeling [23, 24].
Table 1: FDA approved decellularized scaffolds [18, 23]
Products
OASIS Wound Matrix ®
PriMatrix ®
GraftJacket ®
Integra ®
MatriDerm ®
MySkin
EpiCel ®
Theraskin
Regranex ®

Composition
Acellular porcine small intestine submucosa
Acellular fetal bovine dermis
Acellular human dermis
Bilayer matrix bovine collagen and silicon
Bovine collagen fibrils with elastin
Cultured autologous keratinocytes on membrane
Cultured autologous keratinocytes
Human allogenic split-skin graft with keratinocytes and
fibroblasts
Human recombinant platelet-derived growth factor

Prior to implantation, decellularization i.e. removal of all cellular material, is needed
to prevent immune responses. Poor decellularization is characterized by a massive
inflammatory response which inhibits or prevents healing [24]. Decellularization is a harsh
process and can affect the concentration of growth factors and proteins in these scaffolds
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[15]. Along with limited availability, short shelf life, and inability to mass produce;
alternative scaffold materials are needed.
Polymeric Scaffolds
Polymeric scaffolds are composed of biological or synthetic polymers. Biological and
synthetic polymers are currently used to create scaffolds with specific mechanical, chemical,
and biological properties that are tailored to a particular microenvironment. A variety of
biological and synthetic polymers (Table 2) are being researched as scaffolding materials.
Not only can these scaffolds be fabricated with specific characteristics but they can be loaded
with growth factors, proteins, and drugs to aid in wound healing. The bioactivity of
biological polymers has been shown to link certain growth factors i.e. VEGF and hepatocyte
growth factor, to the scaffold, aiding in regeneration [19]. However, these scaffolds suffer
from poor mechanical properties and oftentimes are used in conjunction with synthetic
materials to ameliorate their poor mechanical properties.
Table 2: Polymers for scaffold fabrication
Biological Polymers
Collagen
Chitosan
Alginate
Agarose
Fibrin
Gelatin
Hyaluronic Acid
Silk fibroin

Synthetic Polymers
Poly(glycolic acid) (PGA)
Poly-ε-caprolactone (PCL)
Poly-l-lactic-acid (PLLA)
Polylactic-co-glycolic-acid (PLGA)
Poly(lactic acid) (PLA)
Poly(lactide-co-glycolide) (PLG)
Polypeptites
Poly(acrylic acid) (PAA)
Poly(ethylene oxide) (PEO)
Poly (β-amino ester) (PBAE)

Synthetic polymers have the benefit of tailorable degradation profiles and
architecture; however, these materials are plagued by the fact that they do not readily allow
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cell attachment and are known to stimulate the foreign body response [15, 25]. This issue can
be minimized by the addition of different proteins or macromolecules i.e. arginine–glycine–
aspartic acid (RGD) peptides, to the scaffold’s microstructure [25, 26]. Due to variances in
degradation and mechanical properties some polymers are suited for bone applications;
whereas, others may be better suited for muscle or skin applications.
Poly(β-Amino Ester)
Poly(β-amino ester)s (PBAE), a class of synthetic polymers, were originally
developed for gene and DNA delivery [27-30]. Current research is focused on using PBAEs
as a scaffolding material. PBAEs are composed by step-growth conjugate addition reaction
of diacrylate and amine groups [31, 32] and are known to be biodegradable via hydrolysis of
the ester bonds and biocompatible [27, 33]. The byproducts from PBAE degradation are
several small nontoxic molecules which can be readily cleared prior to reaching toxic levels
[27, 34, 35]. Dependent upon the diacrylate and amine groups, tailorable degradation
profiles, mechanical properties and shapes can be synthesized [27, 28, 33]. Designing PBAEs
with certain physical, chemical, and mechanical properties allows for a multitude of
applications.
Polymer Crosslinking
Different physical and chemical methods are being employed for polymeric
crosslinking e.g. radical polymerization, high energy irradiation, enzymatic crosslinking,
ionic interactions, and crystallization [36]. These different crosslinking methods allow for
polymers to be fabricated with specific structure and properties. While these processes can
crosslink polymers, they also produce unintended effects such as high cytotoxicity, low
crosslinking, poor mechanical properties, etc. As such, choosing the method of crosslinking
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is just as important as selection of the polymer. Photopolymerization is one of the primary
methods used to crosslink polymeric materials. Despite toxic solvents and photoinitiators
needed for crosslinking, UV irradiation is the primary crosslinking method for biomedical
applications [37, 38]. To minimize the effect of harmful UV irradiation, current research has
been working with different visible light irradiation sources i.e. green light, red light, and
blue light (BL) [39-42]. One study is attempting to crosslink methacrylated hyaluronan with
green light irradiation to act as an injectable tissue repair treatment system [41].
Significance
The goal of this project was to develop and characterize a BL crosslinked PBAE, with
the long term aim of in vivo crosslinking for VML applications. BL irradiation was chosen
due to its slightly longer wavelength which has been shown to promote antimicrobial,
antibacterial, and anti-inflammatory effects. [43-46]. In order for BL crosslinking to occur, a
photoinitiator with an appropriate absorption spectra was selected. However, due to BL
photoinitiator solubility issues, the BL crosslinking system was altered from the common UV
crosslinking method to include BL irradiation and a water-soluble photoinitiator. With these
changes, the BL system would be expected to minimize toxicity issues that the UV
crosslinking method experienced.
The overall goal was to characterize BL PBAE scaffolds created by this method and
compare it to the common UV crosslinking method. This was achieved by studying the
systems physical and mechanical properties i.e. degradation and swelling profiles, changes in
supernatant pH, Young’s modulus under tension and compression, and hydrogel
microarchitecture.
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METHODS AND MATERIALS
Materials
Polyethylene glycol diacrylate (PEGDA 400) and diethylene glycol diacrylate
(DEGDA) purchased from Polysciences, Inc. (Warrington, PA). Tetraethylene glycol
diacrylate (TEGDA) purchased from TCI America (Portland, OR). Isobutylamine purchased
from VWR international (Philadelphia, PA.). The photoinitiator (2,2'-Azobis[2-methyl-N-(2hydroxyethyl)propionamide] (VA-086) was purchased from Wako Pure Chemical Industries,
Ltd. (Richmond, VA). 2,2-Dimethoxy-2-phenylacetophenone (DMPA) and Ketoprofen was
purchased from Sigma-Aldrich, Inc. (St. Louis, MO). Dichloromethane (DCM) and ethanol
(EtOH) purchased from Pharmco-AAPER (Shelbyville, KY). Vancomycin was purchased
from Gold Biotechnology (St. Louis, MO).
Macromer Synthesis
Polyethylene glycol diacrylate (H), diethylene glycol diacrylate (A) and tetraethylene
glycol diacrylate (D) were reacted with isobutylamine (6) using a 1.2:1 molar ratio of total
acrylate to amine to form five different macromers [33, 47-49].
(B)

(A)

A

6

A

D
H

6
Macromer A6

Figure 4: (A) Chemical structures of diacrylates and amine used to form macromers. (B)
Macromer synthesis reaction.
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Three single acrylate macromers were synthesized: H6, D6, and A6.

While

maintaining the molar ratio of total acrylate to amine, two macromers were synthesized with
a 3:1 ratio of D to H (DH6 3:1) or A to H (AH6 3:1). These chemicals were pipetted into a
round bottom flask with a magnetic stirrer. The flask was then placed in a silicon oil bath at
85°C and allowed to stir for 48 hours, at which point the reaction was quenched by cooling
the macromer to 8° C. Macromer molecular weight was verified by gel permeation
chromatography.
Hydrogel Fabrication
Hydrogel samples were fabricated by free radical solution polymerization using either
BL or UV to irradiate the solutions [33, 49]. For UV polymerization macromer solutions
were synthesized by combining macromers with 1% (w/w) DMPA in 80% (w/w) DCM as
compared to the macromer. For BL polymerization, macromer solutions followed similar
preparation methods but the macromer was mixed with 2.8% (w/w) VA-086 in 80% (w/w)
deionized water. To study the properties of both crosslinking systems, a variety of sample
geometries were fabricated i.e., dogbones, discs, and cylinders. Due to differences in shape
and solution volume, irradiation times varied from shape to shape. For dogbones and discs,
the macromer solutions were pipetted between two glass slides separated by a 1.7 mm thick
Teflon spacer and irradiated for 5 minutes with UV or 20 minutes by BL. Once crosslinked
samples were then cut with either a 7.5 mm diameter punch or an ASTM D-1708 standard
microtensile sample die. For cylinders, the macromer solution was pipetted into a glass
cylinder mold, 5.8 mm diameter, and irradiated, with UV or BL, for 1 hour while being
circumferentially exposed to the light on an in-house built instrument. Samples were then
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washed overnight in an ethanol bath and allowed to dry. Once dried, cylinder samples were
cut to a height to diameter ratio of 1.5:1.
PBAE Characterization
In Vitro Degradation
After measuring their initial mass, hydrogel discs were placed into 48-well plates,
immersed in 1 ml of phosphate-buffered saline (PBS), pH 7.4, and gently shaken at 37 °C. At
hydrogel dependent time points, hydrogel and PBS supernatant samples were collected. PBS
supernatant samples were stored in 3 ml aliquots at -20 °C. For all samples the PBS
supernatant was renewed in order to prevent the buildup of acidic supernatants. Once
removed, hydrogel samples were dried of excess PBS and the wet mass was measured and
compared to its initial mass to determine the swelling ratio. Samples were then stored at -20
°C for the duration of hydrogel degradation and then lyophilized for two days. Dry masses
were then measured and compared to their initial masses to determine mass loss.
Porosity
Hydrogel porosity was calculated by Scanco Medical X-ray microtomography
(micro-CT). After dry mass measurements were taken, a triplicate of hydrogel samples from
four specific degradation time points were taken and frozen at -20°C overnight and then
lyophilized for two days. Samples were chosen to capture changes in hydrogel morphometry
at critical points during degradation, i.e., the time points at the beginning, end, and before
and after significant mass loss. Hydrogel microarchitectural differences were calculated by
micro-CT analysis software. By measuring the area from each X-ray image, the micro-CT
analysis software was able to calculate the porosity, pore size, and wall thickness between
pores in the crosslinked hydrogels.
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Mechanical Testing
Evaluation of hydrogel modulus was accomplished by using a Bose Electroforce
3300 series test instrument with a 225 N force sensor measuring the load and deformation
under confined compression and tensile testing. A strain rate of 0.05 mm/s and a preload of
0.1 N was selected for both compression and tensile testing. For compression and tensile
sample geometries refer back to the hydrogel fabrication section, page 13. For compression
testing, metal compression heads were mounted to the Bose system. Cylinder samples were
then placed between two compression heads and compressed to 30% strain. For tensile
testing, grips were attached to the movable heads of the Bose system. Silicone spacers were
placed on both sides of the dogbone head, as to minimize failure and slippage near the grip
section. Samples were placed in the grips and stretched to remove slack. The sample was
then placed under tension until failure. For each sample run, the time (s), displacement (mm),
and load (N) were collected in order to calculate the modulus. The modulus was calculated
from the initial linear elastic region of the stress-strain curve.
Drug Release Pilot Study
DH6 (BL) 3:1 and DH6 3:1 were studied for their respective release patterns. DH6
(BL) 3:1 was loaded with vancomycin while DH6 3:1 was loaded with ketoprofen. Both
drugs were loaded at 10% (w/w) as compared to the macromer. After crosslinking, 7.5mm
diameter samples were punched and placed into a 48-well plate and immersed in PBS. Every
twelve hours supernatant was withdrawn, put into 6 ml tubes, and frozen. After a four day
collection period, samples were thawed and measured by a BioTek PowerWave HT UV-Vis
plate reader. Drugs were measured at different wavelengths: vancomycin (280 nm) and
ketoprofen (310 nm).
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Statistical Analysis
A two-way analysis of variance (ANOVA) and Tukey’s HSD post-hoc was run using
R studio to statistically analyze the results for in vitro degradation and micro-CT studies. For
mechanical testing, two-way ANOVA and multiple comparison post-hoc analysis was run
using Matlab. Statistical significance was established at p values less than 0.05.
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RESULTS
Degradation Study
PBAE Degradation & Swelling Profiles
PBAEs showed predictable degradation profiles, which exhibited minimal mass loss
prior to a hydrogel-specific critical point, i.e. A6 day 30, D6 day 10, AH6 3:1 day 3.5, DH6
3:1 day 1.5, and H6 two hours, after which the samples began to rapidly lose mass, as seen in
Figure 5 (a). Likewise, these critical points are near the maximum swelling of the hydrogels
as seen in Figure 5 (b).
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Figure 5: Polymer degradation (a) and swelling (b) profiles for all UV hydrogels. Data are
mean ± standard deviation (n = 9).
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BL and UV Degradation Profiles
BL and UV hydrogels follow the typical degradation profile as seen in Figure 1.1, but
BL hydrogels are shown to degrade differently compared to their UV counterparts: AH6
(BL) 3:1 degraded slower, H6 (BL) degraded quicker, and DH6 (BL) 3:1 degraded at the
same speed (Figure 6). Two-way ANOVA showed statistically significant differences with
respect to time point, crosslinking method, and the interaction between time point and
crosslinking method (p < 0.05).
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Figure 6: BL and UV degradation profiles for hydrogels (a) AH6 3:1, (b) DH6 3:1, and (c)
H6. Data are mean ± standard deviation (n = 9). Data sets AH6 3:1 and H6 exhibit UV and
BL degradation curves which are statistically different (p< 0.05) after time point day 4 and
hour 1.25, respectively.
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BL and UV Swelling Profiles
BL and UV PBAEs displayed significant differences when it came to swelling
behavior, swelling from four to eight times their original mass (Figure 7). Two-way ANOVA
shows that AH6 3:1, DH6 3:1, and H6 BL hydrogels were significantly different from their
UV counterparts with respect to time point, crosslinking method, and the interaction between
time point and crosslinking method (p < 0.05).
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Figure 7: BL and UV swelling profiles for (a) AH6 3:1, (b) DH6 3:1, and (c) H6. Data are
mean ± standard deviation (n = 9). All data sets are significantly different (p < 0.001) after
time point day 1.26 (AH6 3:1), day 1.5 (DH6 3:1), and hour 0.66 (H6).
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X-ray microtomography
MicroCT showed changing microarchitecture within the hydrogels during
degradation. Throughout degradation BL hydrogels showed increasing porosity (Figures 8a),
consistent pore sizes (Figure 8b), and decreasing wall thickness between pores (Figure 8c).
Two-way ANOVA showed statistically significant differences between BL and UV
hydrogels (Figure 9) showing statistical differences in porosity, pore size and wall thickness
(p < 0.05)
.
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Figure 8: Hydrogel porosity, pore size, and wall thickness between pores shown. Data are
mean ± standard deviation (n = 3).
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Figure 9: Evaluating hydrogel microarchitecture of BL and UV crosslinking methods. Data
points which are significantly different are marked with a bar and asterisks (*) (p < 0.05).
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pH Profiles
The supernatant for hydrogels A6 and D6 started at a pH of 7.4, but near the critical
point of mass loss, the pH dropped to a pH of 6.5 and then rose back to a pH of 7 (Figure 10).
Instead of following this pattern, the other hydrogels, AH6 3:1, DH6 3:1, and H6, started
with a pH slightly above 7.4 and showed a 0.5 pH unit drop over the span of degradation
(Figure 11). Two-way ANOVA showed a statistically significant difference with respect to
time point, crosslinking method, and the interaction between time point and crosslinking
method (p < 0.05).
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Figure 10: pH of the hydrogel supernatant for A6 and D6. Data are mean ± standard
deviation (n = 3).
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Figure 11: pH measurements for (a) AH6 3:1, (b) DH6 3:1, and (c) H6. Data are mean ±
standard deviation (n = 3). Data points which are significantly different (p < 0.05) are marked
with asterisks (*).
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Mechanical Study
Compressive and Tensile Modulus
Load-deformation curves (Figure 12) were used to construct compressive (Figure
13a) and tensile (Figure 13b) stress-strain curves. These curves were then used to calculate
the mean (Figure 14) and average (Table 3) modulus. BL hydrogels exhibited decreased
compressive and tensile modulus as compared to UV crosslinked hydrogels. Two-way
ANOVA showed statistically significant differences between crosslinking methods with BL
and UV hydrogels AH6 3:1 and DH6 3:1 being statistically different (p < 0.05).
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Figure 12: Representative load-deformation curves for (a) compression and (b) tensile testing
of sample AH6 3:1
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(a)

(b)

Figure 13: Representative stress-strain curves for (a) compression and (b) tension. Red line
indicates the slope of the given data used for calculating the modulus.
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(a)

(b)

Figure 14: Modulus for (a) compression and (b) tension. Data are mean ± standard deviation
(n = 4). Outliers are denoted by red plus signs.
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Table 3: Average modulus of hydrogels.
Hydrogel

Average Compressive Modulus (KPa)

Average Tensile Modulus (KPa)

A6

1633 ± 607

801 ± 192

D6

1489 ± 725

835 ± 117

AH6 3:1*

1589 ± 499

821 ± 251

AH6 (BL) 3:1*

291 ± 204

279 ± 135

DH6 3:1*

1087 ± 798

776 ± 182

DH6 (BL) 3:1*

281 ± 194

160 ± 81

H6

840 ± 279

337 ± 129

H6 (BL)

313 ± 58

201 ± 96

* BL and UV crosslinked hydrogel means which are statistically different are marked with
asterisks (*) (p < 0.05)
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Drug Release Pilot Study
Vancomycin and ketoprofen release from DH6 3:1 hydrogels. Vancomycin-loaded DH6 (BL)
3:1 hydrogels showed an initial burst release with a slow continual release until the end of the
study. Ketoprofen-loaded DH6 3:1 hydrogels showed variable release patterns with a burstlike release in the middle of the study and an average release of almost four times that of
vancomycin (Figure 15).
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Figure 15: Release of vancomycin and ketoprofen from DH6 3:1 BL and UV hydrogels,
respectively (n = 1).
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DISCUSSION
Poly(β-amino ester)s, originally developed for gene and DNA delivery applications,
have drawn significant interest as a scaffolding material. PBAEs have been previously
reported as a safe biocompatible material [50, 51], with tailorable degradation profiles [33]
and a wide range of mechanical properties [52]. In dealing with soft tissue injuries,
appropriate degradation times and mechanical properties are necessary for tissue regeneration
and cell penetration. Wound healing can take up to a year, depending upon the severity of the
wound. Therefore, overall degradation needs to span a couple of weeks to allow the
surrounding tissues enough time to replace the scaffold while not inhibiting tissue
regeneration [15, 52-54]. In one study complete skeletal muscle formation occurred in 5 days
[54]. BL PBAEs AH6 3:1 and DH6 3:1 lost 20% and 42% of their initial mass over 9.5 and
3.5 days, while their UV counterparts lost 41% and 50% of their initial mass over the same
time, respectively. The degradation profiles for these PBAEs are shown to be appropriate for
the formation of new skeletal muscle. Appropriate mechanical properties are also needed as
they have been shown to influence cellular interactions i.e. cell adhesion and contractility
[55], affect properties i.e. swelling [52], and play a key role in the wound healing process
[56]. Skeletal muscle has been shown to have an average Young’s modulus of ~10 kPa [5759] but has shown maximum values nearing 60 kPa [57, 59]. BL PBAEs AH6 3:1 and DH6
3:1 exhibited an average tensile modulus of 279 ± 135 kPa and 160± 81 kPa which is vastly
decreased from the average tensile modulus of 821 ± 251 kPa and 776 ± 182 kPa posted by
their UV counter parts.
PBAE degradation profiles and mechanical properties can be altered by changing
either the diacrylate or amine in the macromer. In this research, varying the diacrylate elicited
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different mechanical strengths and tailorable degradation profiles. Each diacrylate had a
variance in the number of oxygens located in their monomer chain; see Figure 4 on page 12.
This difference directly affected the hydrophobicity of the macromer, as having more oxygen
in the monomer chain led to faster overall swelling and degradation.
Macromer molecular weight plays a role in PBAE degradation, swelling, and
mechanical strength [27, 60]. Decreases in macromer molecular weight have been shown to
cause increased crosslink density [28], therefore increasing the modulus and decreasing
overall time of degradation. Variances in molecular weight allow for the formation of
matrices with slightly different crosslink densities, which could cause minor variances in
degradation, swelling, and mechanical properties. While macromer molecular weight could
have an effect on degradation, swelling, and mechanical properties of PBAEs, it was not a
focus of this research.
UV photopolymerization is the most common method of polymer crosslinking. This
system boasts quick reaction times, with minimal heat production under physiological
temperatures resulting in uniform hydrogel properties [61, 62]. This method is a double
edged sword, as free radicals are needed for polymer crosslinking; yet, prolonged exposure to
irradiation and free radicals [62] cause issues such as radiation safety and curing depth
limitations [63]. Interest in visible light irradiation sources i.e. BL, have seen increased
interest due to increased irradiation safety and energy utilization efficiency [63].
BL photopolymerization elicits different physical and mechanical properties as
compared to the standard method. In this research BL crosslinking was impossible for two of
these macromers: A6 and D6. These macromers were composed of diacrylates that had lower
number of oxygens in their macromer chain which resulted in increased macromer
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hydrophobicity. Attempting to mix the macromer with the aqueous photoinitiator solution
resulted in a heterogeneous mixture which failed to crosslink. AH6 3:1 and DH6 3:1 faced
similar issues but mixed completely, resulting in an opaque viscous solution which at times
had difficulty crosslinking. H6 mixed completely and resulted in a transparent solution with
an increased amount of gas bubbles.
The PBAEs formed from the BL crosslinking process displayed differences in
degradation, swelling, and mechanical properties. The properties exhibited by these PBAEs,
from their mechanical strength to degradation profile, are controlled by their specific
structure. The combination of hydrophobicity, crosslink density, and microarchitecture
induce hydrogel specific properties.
Hydrophobicity is one of the main factors affecting the structure and properties of
these PBAEs. BL PBAEs are greatly impacted by macromer hydrophobicity, as hydrophobic
macromers have increased difficulty in mixing homogenously. This interaction created an
opaque gaseous slurry, which could be the source of poor crosslinking and increased porosity
and pore size. Degradation and swelling profiles are often dependent upon the
hydrophobicity of their polymer, as the hydrophobic effect regulates the rate at which water
interacts with the ester bonds. This interaction could explain why H6 BL degrades nearly two
hours faster than its UV counterpart, as a good fraction of the bonds holding the matrix
together may have already undergone hydrolysis during the fabrication process. The other
BL hydrogels do not degrade as such, and are affected by other degradation factors affecting
the structure of the hydrogel.
Crosslink density contributes to the different properties seen in BL PBAEs,
specifically mechanical properties. BL PBAEs were difficult to handle as they would
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oftentimes remaining tacky to the touch and tear easily. This suggests poor crosslinking has
occurred, which has been correlated to decreased mechanical strength, increased swelling,
and faster overall degradation [64-68]. BL hydrogels follow this trend seeing decreased
mechanical strength and a massive increase in swelling; however, BL hydrogels AH6 3:1 and
DH6 3:1 deviate from this pattern seeing degradation profiles which initially mimicked UV
hydrogels but near the end of degradation began to see statistically different measurements.
In this case poor crosslinking does not act as the main affecter, as poor crosslinking should
cause a decrease in overall time of degradation, not an increase. A possible explanation for
the slower overall degradation profile is the formation of hydrophobic aggregates. The
degree to which the macromer and water mixed is unknown and could have resulted in the
formation of a heterogeneous matrix with hydrophobic aggregates. These areas would inhibit
water infiltration and thus slow degradation.
As seen in the results section, BL hydrogels have higher initial porosities and pore
sizes, seeing increases in both throughout degradation; whereas, UV hydrogels maintained
minimal porosity and constant pore sizes. H6 did not follow this trend, as both UV and BL
samples had similar porosities and pore sizes throughout degradation. Hydrogel
microarchitecture has been shown to influence mechanical strength and swelling capacity, as
increased porosity and pore size indicate increased swelling ratios [67, 69] and decreased
mechanical strengths [65, 66, 69].
During the degradation process there is a point prior to hydrogel mass loss that sees
alterations in degradation, swelling, and pH profiles. Beyond this critical point, the hydrogel
loses mass at a significant rate, sometimes losing as much as 30% of the original mass within
a few measurements. At this point during degradation, there is a noticeable drop in pH for
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two of the more hydrophobic hydrogels: A6 and D6. All other hydrogels see only a slight
drop in the pH over the period of degradation. During the process of hydrolysis, ester bonds
are broken down into carboxylic acid and an alcohol. One possibility for the difference in pH
between hydrogels is different rates of PBAE degradation. Different PBAE degradation rates
would cause different rates of acid production possibly explaining the buildup of acid in
PBAEs A6 and D6. While there are periods of increasing acidity, the body is able to regulate
the pH of the interstitial fluid thus clearing any acidic build up from the body. A stable pH
level is critical for the scaffolds integrity and biocompatibility, as too much acidic stress
could induce an inflammatory response preventing proper integration and eventually leading
to massive fibrosis.
BL PBAEs demonstrate the ability to release drug from their matrix in a controllable
manor. Controlled release of drugs or growth factors to attain therapeutic levels is a high
priority in the field of tissue engineering. With controllable degradation and swelling
profiles, PBAEs exhibit their ability to release growth factors and other therapeutic drugs for
tissue regeneration applications [70, 71]. Current PBAE systems utilize an organic solvent
system which lacks the ability to homogenously distribute water-soluble drugs throughout
the scaffold. BL PBAEs are able to achieve uniform water-soluble drug distribution.
Vancomycin and ketoprofen were used to look at the release patterns of drugs from the BL
and UV crosslinked PBAEs. These drugs were selected for their solubility in each solvent
system. PBAEs released their respective drugs at slightly different levels at different times.
UV samples seemed to release a majority of their drugs near the end of the study while BL
hydrogels tended to release their drug at the beginning of the study. Vancomycin is relatively
larger than ketoprofen; however, the difference in size does not seem to play a major role in
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the release of these drugs. If size played a role then ketoprofen, being the smaller molecular
weight drug, would release most of the drug at the beginning of the study. One explanation is
differences in hydrogel structure. BL hydrogels have been shown to be poorly crosslinked
leading to the possibility of early release from the matrix; whereas, UV hydrogels have an
increased crosslink density allowing for the drug to stay longer inside of the matrix. BL
hydrogels released a lower amount of total drug suggesting poor loading. One explanation for
the lower drug release is the EtOH washing phase. As the hydrogel undergoes washing to
remove any unreacted monomers and photoinitiator solutions, the drug may have been
washed away as well only leaving the strongly entrenched drug molecules behind. As a proof
of concept, drugs can be loaded and released from the BL hydrogels.
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CONCLUSION
Understanding how changes in hydrogel structure and properties affect their function
gives great insight to their possible applications. The aim of this project was to develop a
hydrogel system with the future aim being a regenerative strategy for wound healing
applications. This research developed BL PBAE hydrogels and evaluated the differences
between UV and BL hydrogels. BL PBAEs exhibit increased swelling ratios, prolonged
degradation, and a decreased modulus. The properties of these PBAEs have mechanical
strengths and degradation profiles that are appropriate for use in skeletal muscle scaffolding
systems. BL PBAEs could be used in drug delivery applications for the delivery of watersoluble drugs due to their degradation and swelling profiles. Further study is needed to attain
appropriate mechanical properties and evaluate the possible drug release applications of BL
PBAEs.
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APPENDIX
CELL STUDIES
Materials
Trypan blue and Dulbecco’s modified Eagle’s medium (DMEM) purchased from
HyClone (Logan, UT). Thiazolyl blue tetrazolium bromide (MTT reagent), Bovine Serum
Albumin (BSA), and Hoechst 33258 purchased from Thermo Fisher Scientific Chemicals
Inc. (Ward Hill, MA)., Fibronectin, collagen I, collagen III, and tenascin C purchased from
Millipore Sigma (Burlington, MA).
Methods
To understand how different ECM backgrounds alter cellular proliferation and
attachment; a comparison between the regenerative Acomys (SM1) and the non-regenerative
Mus musculus (M2) was completed. Immortalized fibroblast cell lines from these animals
were seeded on different coating backgrounds and assayed. Six different coating
backgrounds were selected for this study: fibronectin, collagen I, collagen III, tenascin C,
bovine serum albumin (BSA), and tissue culture plastic (TCP).
Table 4: Protein Concentration
Protein

Concentration (μg/ml)

Tenascin C

1.52

Fibronectin

1.73

Collagen I

1.73

Collagen III

1.17

Albumin

0.92

These ECM protein backgrounds were coated on 24-well TCP plates at
concentrations to obtain a surface density that would form a protein monolayer (Table 3) [72,
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73]. Each well was coated by adding 100 μL of an individual protein concentration and were
given two hours at room temperature for protein adsorption. The plates were then washed
twice with PBS and a 5% BSA in PBS blocking solution was applied for 2 hours at room
temperature. Wells were washed with PBS two more times and air dried and stored at 2-8 °C
for future use. Both cell lines were detached and seeded using basic cell culture methods. The
attachment assay was seeded at 40,000 cells per well, while the proliferation assay was
seeded at 1.000 cells per well.
Both assays were allowed to run for specified times as to observe the attachment and
proliferation of the individual cell lines. The attachment assay had four time points at 0.5, 1,
2, and 4 hours, while the proliferation assay was measured once daily for six days. The
assays were measured using the Hoechst DNA quantification protocol [74]. At the time of
lysis, cells are washed twice with PBS, and 1 ml of a lysis buffer (0.05 M NaH 2PO4, 2 M
NaCl, 2 mM EDTA, pH 7.4) was added. Each well was sonicated two times for 10 seconds,
and 0.25 ml of 2 μg/ml Hoechst 33258 was added to each well, shaken gently, and left at
room temperature in the dark for 10 minutes. Fluorescence was measured at λ ex = 356 nm
and λem = 458 nm.
Preliminary Results
Initial results showed differences in attachment and proliferation, both qualitatively
and quantitatively. Mus fibroblasts showed to attach quicker and at higher numbers, while
Acomys fibroblasts showed increased proliferation. Prior to starting the study was unable to
keep healthy low passage cell lines. Study was halted as to focus on material study. Two-way
ANOVA showed statistical differences in proliferation between Acomys and Mus fibroblasts
(p = 0.05); however, attachment was not statistically different.
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Figure 16: Mus and Acomys fibroblast (a) attachment and (b) proliferation studies. Cells
were seeded at 40K and 1K for attachment and proliferation studies. Red line indicates cell
seeding. Data are mean ± standard deviation (n=3).
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Discussion
There is a prevalent need to understand how cellular attachment and proliferation are
affected by different protein backgrounds. Understanding cellular responses to different
protein backgrounds will allow future work to focus on the best protein combination to aid in
a wound healing environment.
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